Effects of NADPH Oxidase Isoform-2 (NOX2) Inhibition on Behavioral Responses and Neuroinflammation in a Mouse Model of Neuropathic Pain

Autores da FMUP
Participantes de fora da FMUP
- Teixeira Santos, L
- Verissimo, E
- Martins, S
- Albino-Teixeira, A
Unidades de investigação
Abstract
NADPH oxidase isoform-2 (NOX2) has been implicated in the pathophysiology of neuropathic pain (NP), mostly through the modulation of neuroinflammation. Since it is also accepted that some neuroimmune mechanisms underlying NP are sex-dependent, we aimed to evaluate the effects of early systemic treatment with the NOX2-selective inhibitor (NOX2i) GSK2795039 on behavioral responses and spinal neuroinflammation in spared nerve injury (SNI)-induced NP in male and female mice. Mechanical sensitivity was evaluated with the von Frey test, while general well-being and anxiety-like behavior were assessed with burrowing and light/dark box tests. Spinal microglial activation and cytokines IL-1 beta, IL-6, and IL-10, as well as macrophage colony-stimulating factor (M-CSF) were evaluated by immunofluorescence and multiplex immunoassay, respectively. NOX2i treatment reduced SNI-induced mechanical hypersensitivity and early SNI-induced microglial activation in both sexes. SNI-females, but not males, showed a transient reduction in burrowing activity. NOX2i treatment did not improve their burrowing activity, but tendentially reduced their anxiety-like behavior. NOX2i marginally decreased IL-6 in females, and increased M-CSF in males. Our findings suggest that NOX2-selective inhibition may be a potential therapeutic strategy for NP in both male and female individuals, with particular interest in females due to its apparent favorable impact in anxiety-like behavior.
Dados da publicação
- ISSN/ISSNe:
- 2227-9059, 2227-9059
- Tipo:
- Article
- Páginas:
- 416-
- Link para outro recurso:
- www.scopus.com
Biomedicines MDPI AG
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- neuropathic pain; spared nerve injury; NOX2; GSK2795039; pain-related behavior; neuroinflammation; sex differences
Proyectos asociados
Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and therapeutic targets. (severe COVID-19)
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Severe COVID-19) . FCT . 2020
Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal diseases
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Endocan) . 2020
Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation and oxidative stress.
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Renal) . 2021
Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship with organ dysfunction in human septic shock
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2021
Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Endothelial dysfunction in different stages of diseases severity of COVID-19: focus on endocan and arterial hypertension
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Citar a publicação
Teixeira L,Verissimo E,Martins S,Sousa T,Albino A,Pinho D. Effects of NADPH Oxidase Isoform-2 (NOX2) Inhibition on Behavioral Responses and Neuroinflammation in a Mouse Model of Neuropathic Pain. Biomedicines. 2023. 11. (2):p. 416-416. IF:4,700. (1).